What is the Buying Price of Gland Pharma Share?

The Buying Price of Gland Pharma share is 2277 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Gland Pharma Share at Choice?

To buy Gland Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gland Pharma, choose your preferred order type, and place the trade.

What is the PE ratio of Gland Pharma Shares?

The Price-to-earnings (P/E) ratio of Gland Pharma shares is 36.77. You can compare it with the sector average for relative valuation.

What is the PB ratio of Gland Pharma Shares?

The Price to Book (P/B) ratio Gland Pharma shares is 3.65. Useful to assess the stock's value relative to its book value.

Is Gland Pharma Overvalued?

To assess Gland Pharma’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Gland Pharma?

The Market Cap of Gland Pharma is 37515.04 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Gland Pharma Share Price?

The 52 week high and low prices of Gland Pharma share price is 2396 & 1513.4. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Gland Pharma belong to?

Gland Pharma belongs to the Healthcare sector.

Gland Pharma Share price

GLAND

Healthcare Large Cap

2277

15.40 (-0.67%)

NSE

BSE

Last updated on 2 Jun, 2026 | 15:49 IST

BUYSELL

Today's High

2337.50

Today's Low

2263.20

52 Week Low

1513.40

52 Week High

2396.00

Free Demat with Zero AMC*

Gland Pharma Chart

ChartIQ

TradingView

Gland Pharma Share Key Metrics

Volume

4.82 L

Market Cap

37515.04 CR

LTQ@LTP

4@2277.00

ATP

2295.73

Var Margin

17.07 %

Circuit Range

1834-2750.8

Delivery %

46.87 %

Value

110.67 CR

ASM/GSM

No

Market Lot

1

Summary

2 Jun, 2026 | 15:49 को, Gland Pharma का शेयर प्राइस आज ₹2277 पर है, जो दिन के लिए 15.40% की -0.67 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹2263.20 और ₹2337.50 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1513.40 से ₹2396.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Gland Pharma ने 482075 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹164756423 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹229573 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 4,227700 रही। यह स्टॉक ₹1834-2750.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹110.67 CR है। दिन के लिए डिलीवरी परसेंटेज 46.87% रही। इसके अतिरिक्त, Gland Pharma वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Gland Pharma Fundamentals

P/E Ratio

36.77

P/B Ratio

3.65

Div. Yield

0.87

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Gland Pharma Resistance and Support

Pivot 2301.57

Resistance

First Resistance

2347.34

Second Resistance

2402.27

Third Resistance

2448.04

Support

First Support

2246.64

Second Support

2200.87

Third Support

2145.94

Gland Pharma Shareholding Pattern

2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

51.83%

Mutual Fund

31.78%

Insurance

1.35%

Foreign Institutional Investors

7.29%

Domestic Institutional Investors

0.23%

Retail

7.52%

Others

0%

Total Promoters

MAR '26

51.83%

Gland Pharma Corporate Actions

Date	Agenda
2026-05-15	Audited Results & Final Dividend
2026-01-28	Quarterly Results

Gland Pharma News

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings in June 2026. The meetings include a one-on-one with Carnelian Asset Management and participation in the ICICI Securities India Investor Conference.

May 26 2026 15:34:26

Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook

Gland Pharma reported robust Q4 FY26 consolidated net profit of ₹366.7 crore, a 96.6% year-on-year increase, with revenue rising 22.3% to ₹1,742.8 crore, driven by strong performance in its injectables business and CDMO operations. The company's positive outlook is further strengthened by the recovery of its European unit Cenexi, planned new product launches, and significant capacity expansion, including a 250% increase in GLP-1 production. A final dividend of ₹20 per share for FY26 has also been proposed, with a record date of August 11, 2026.

May 21 2026 06:20:23

Gland Pharma shares gain most in nearly three years after Q4 results, brokerage upgrade

Gland Pharma reported a robust financial performance for Q4 FY26, with its consolidated net profit surging by 96.6% year-on-year to ₹366.68 crore and revenue from operations increasing by 22.3% to ₹1,742.79 crore. This strong performance, attributed to higher revenues and improved operating leverage, resulted in a significant positive reaction in the company's shares. The board also recommended a final dividend of ₹20 per share.

May 18 2026 10:31:13

Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividend

Gland Pharma reported a 97% year-on-year surge in its Q4 FY26 consolidated net profit, reaching ₹366.7 crore, primarily driven by strong growth in its CDMO business and improved operational efficiency. Following these robust results, the company also announced a final dividend of ₹20 per share.

May 18 2026 10:09:03

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Gland Pharma has uploaded the audio recording of its Q4 FY26 earnings call, which took place on May 15, 2026, to its official website for investor access.

May 15 2026 21:14:34

Gland Pharma Ltd - 543245 - Board Fixes Record Date Of August 11, 2026 For The Final Dividend

Gland Pharma has fixed August 11, 2026, as the Record Date for its final dividend of ₹20 per equity share for FY26. Shareholders as of this date will be eligible, with payment due within 30 days after the August 25, 2026 AGM.

May 15 2026 16:49:41

Gland Pharma Ltd - 543245 - Corporate Action-Board approves Dividend

Gland Pharma Board recommended a final dividend of ₹20 per equity share for FY26. The record date is August 11, 2026, with payment due within 30 days of the AGM.

May 15 2026 16:46:50

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Gland Pharma reported strong Q4 FY26 results with consolidated revenue increasing 22% YoY to Rs.17,428 Mn. Adjusted net profit saw a significant rise of 97% YoY to Rs.3,667 Mn, driven by robust performance across segments.

May 15 2026 16:42:05

Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting - 15052026

Gland Pharma reported strong Q4 FY26 cons. revenue of ₹17,428 Mn, marking a 22% YoY increase, and net profit of ₹3,667 Mn, up 97% YoY. The company's board also recommended a final dividend of ₹20 per equity share for FY26.

May 15 2026 16:20:32

Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Gland Pharma shareholders passed a special resolution to reappoint Ms. Naina Lal Kidwai as an Independent Director with 94.18% votes in favour. The approval also includes her remuneration as commission on profits.

May 14 2026 18:28:01

Name	Position
Sampath Kumar Pallerlamudi	Company Secretary & Compliance Officer
Srinivas Sadu	Chairman

Gland Pharma Similar Stocks

Anthem Biosciences Ltd.

755.60

1.55 (0.21%)

Narayana Hrudayalaya Ltd.

1934.20

29.70 (1.56%)

Ipca Laboratories Ltd.

1507.70

17.30 (1.16%)

Aster DM Healthcare Ltd.

726.95

6.00 (0.83%)

Glaxosmithkline Pharmaceuticals Ltd.

2188.80

-15.60 (0.71%)

Ajanta Pharma Ltd.

2912.20

-18.80 (0.64%)

JB Chemicals & Pharmaceuticals Ltd.

2129.60

-10.60 (0.50%)

Wockhardt Ltd.

1966.20

-186.70 (8.67%)

Emcure Pharmaceuticals Ltd.

1704.40

-0.80 (0.05%)

Gland Pharma FAQs

Gland Pharma शेयर का खरीद मूल्य 2277 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Gland Pharma शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Gland Pharma शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 36.77 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Gland Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.65 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Gland Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.97 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Gland Pharma का मार्केट कैप 37515.04 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Gland Pharma शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2396.00 और 1513.40 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।